Is Idera Pharmaceuticals Inc (NASDAQ:IDRA) a Buy? The Stock Reported Less Sellers

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Logo

The stock of Idera Pharmaceuticals Inc (NASDAQ:IDRA) registered a decrease of 2.6% in short interest. IDRA’s total short interest was 1.58 million shares in September as published by FINRA. Its down 2.6% from 1.62M shares, reported previously. With 367,600 shares average volume, it will take short sellers 4 days to cover their IDRA’s short positions. The short interest to Idera Pharmaceuticals Inc’s float is 7.08%.

The stock increased 4.93% or $0.148 during the last trading session, reaching $3.148. About 108,513 shares traded. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) has declined 58.78% since September 13, 2018 and is downtrending. It has underperformed by 58.78% the S&P500.

Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of oligonucleotide therapeutics for oncology and rare diseases in the United States. The company has market cap of $90.80 million. It uses two drug discovery technology platforms to design and develop drug candidates, including toll-like receptor targeting technology and third-generation antisense technology. It currently has negative earnings. The companyÂ’s drug candidates include IMO-2125, an agonist that is in Phase I/II clinical trials in combination with ipilimumab and pembrolizumab for the treatment of anti-PD-1 refractory metastatic melanoma and refractory solid tumors; IMO-8400, an antagonist, which is in Phase II clinical trial for the treatment of dermatomyositis.

More notable recent Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) news were published by: Seekingalpha.com which released: “Idera up 8% on early-stage tilsotolimod data – Seeking Alpha” on April 02, 2019, also Seekingalpha.com with their article: “Oppenheimer likes Incyte in premarket analyst action – Seeking Alpha” published on September 05, 2019, Streetinsider.com published: “Idera Pharmaceuticals to Present at the Baird 2019 Global Healthcare Conference – StreetInsider.com” on August 30, 2019. More interesting news about Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) were released by: Benzinga.com and their article: “60 Biggest Movers From Yesterday – Benzinga” published on September 05, 2019 as well as Globenewswire.com‘s news article titled: “Idera Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference – GlobeNewswire” with publication date: January 04, 2019.

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.